Member Info for comeonvog

BUT...... Accordingly, the Board believes the Project will generate first revenues in production year one, with positive cash flows, pre debt financing costs, expected from end of year three.

eviking why would that be , last placing at 2p

And like i would take advice from mannnan , na don't think so. O look back to 2.5p

Look boy's and girl's , last placing was at 2p with no news. No big deal.

What was the price of gold in 2017.

GEO Managing Director Greg Kuenzel said, "Together with the initial Mineral Resource estimate of 2.29Mt @ 0.85g/t Au, including an optimised In-Pit Mineral Resource of 1.14Mt @ 1.10g/t Au, we recently announced for the gold oxide deposit at GZ2, the discovery of the new breccia pipe at GZ2 has pushed us closer to the Phase 2 target of a 5Mt optimised in-pit combined gold-copper Mineral Resource within the KB project area during 2017. The copper mineralisation is augmented by a gold 'kicker' that in some cases is as high as 0.5g/t Au which will also report to the final copper-gold concentrate as a credit and add significant value.

Wolfofsomewhere it's in a high cash burn sector , so they need the funding. But on the plus side a lot of money has gone into this at a far higher SP the problem here has been Woodford and now Invesco selling down at any price. We only need some big money US backers , the results have all been good IMO

Wolfofsomewhere interim June 30th 2019

As part of the going concern review, the Directors have considered the funding requirements of the Group through consideration of the Group's current business plan and the preparation of detailed cash flow forecasts. Under the current business plan and detailed cash flow forecasts, with ongoing R&D efforts focused on our rare disease products, setrusumab and alvelestat, we expect that our current on-hand cash resources will extend to the end of Q2 2020. Therefore, the Group requires additional external funding within the next 12 months to be able to continue as a going concern. Principally, this funding will be required to complete our current trials, fund our ongoing administrative costs and other general working capital and contractual financing requirements and to commence our pivotal paediatric study and the manufacturing scale up activities for setrusumab as we progress with our development plans for that program.

I think this is why we are down here, get the funding and away we go IMHO

Hi GW , this is ticking along nicely . Is the div 0.25p if so why bother.

waiting a little longer , 120 will do.....maybe

AIMing_high That can be said for most AIM company's and brings into question why are they running them. Life style and kudos with never ending placings for over inflated wages . IMO

Thats me out. 200k stinks and i can see no profit here . I might come in again if it drops to a 50 million MC.

Big volume of trades, have the shorter's done with this stock.

francobrett I thought it was funny , lets be honest Harry is not the best with the truth.

No explanation just final warning. I wonder now if the shorts will close.

Just had my last warning from admin so have to be careful what i say.

But the MC now looks appealing so i have just bought a few .

barchid you have called this spot on and i totally agree about the to highly paid BOD. But now might be the time for to get heads together and work out what this company is worth. The $0.2 million net cash looks a worry to me.

TaffEvans How about all the people you left stranded / spiked . So you were trading while all the time telling people what a good investment, poor form.